IntroductIon
Castrations are common in the United States, with over 15 million occurring annually in bulls (USDA, 2009 ). However, growing concern for animal welfare amongst consumers (Rollin, 2004; Broom, 2010) will require evaluation of pain mitigation options for potentially painful practices and development of methods to identify pain in livestock. Band castration is thought to be painful, based on prolonged wound formation and decreased ADG in band castrates vs. surgical castrates and intact bulls (Fisher et al., 2001) .
In Holstein calves given meloxicam (0.5 mg/kg) or a saline control at scoop dehorning, control calves had greater substance P (SP) concentration, a compound used to identify acute pain response, than meloxicam-treated animals ABStrAct: Two experiments evaluated the effects of band castration and oral administration of an analgesic in association with castration on performance and behavioral and physiological responses in yearling beef bulls. In Exp. 1 Angus and Charolais-crossbred bull calves (n = 127; 309.8 ± 59.04 kg BW) and in Exp. 2 Hereford, Angus, and Hereford × Angus crossbred bulls (n = 30; 300.8 ± 4.96 kg BW) were stratified by BW and randomly assigned to 1 of 3 treatments: 1) band castration (BAND), 2) band castration with oral administration of meloxicam (BAND-MEL), and 3) sham castration (SHAM). The BAND and SHAM procedures were completed on d 0. The SHAM treatment consisted of all animal manipulations associated with band castration without band application. Meloxicam was administered on d -1, 0, and 1 (1.0, 0.5, and 0.5 mg/kg, respectively) via an oral bolus. Body weight and a subjective chute score (CS) were collected on d -1, 0, 1, 7, 14, and 21 (d 28 Exp. 1 only). In Exp. 2, jugular blood samples were collected immediately before castration and 24 h postcastration for substance P (SP)
analysis. In Exp. 2, video documentation on d 0 was used to determine range of vertical head motion (DIST) on a subset of animals during treatment administration. In both experiments, ADG was similar (P ≥ 0.50) between BAND and BAND-MEL, but ADG in SHAM cattle was greater (P < 0.001) and tended (P = 0.07) to be greater than castrates in Exp. 1 and 2, respectively. In Exp. 1, CS did not differ (P ≥ 0.26) between BAND and BAND-MEL on any day, but castrates exhibited less desirable CS on d 1 and 28 than SHAM cattle. In Exp. 2, CS was not affected (P ≥ 0.41) by castration or the presence of meloxicam. In Exp. 2, DIST did not differ (P = 0.57) between BAND and BAND-MEL, but when pooled, castrates exhibited greater (P = 0.04) DIST than SHAM. In Exp. 2, plasma SP concentrations were similar between BAND and BAND-MEL (P = 0.81) and between castrates vs. sham cattle (P = 0.67). Results indicate no impact of meloxicam administration on performance or behavioral and physiological responses to band castration. However, there was a negative impact of castration on ADG and DIST.
of 4-to 6-mo-old beef calves resulted in greater peak plasma SP than simulated castration (Coetzee et al., 2008) . Flunixin meglumine is the only nonsteroidal anti-inflammatory drug (nSAId) in the United States approved for food animals; unfortunately, it is not labeled for analgesia. Therefore, extra-label use of certain NSAIDs for pain relief is permissible under the Animal Medicinal Drug Use Clarification Act and is gaining support in the veterinary community (Smith et al., 2008) . When given at surgical castration to high risk (comingled cattle that traveled from Tennessee to Kansas) beef calves, the NSAID meloxicam did not improve performance but resulted in a reduced first-pull rate vs. untreated controls (Coetzee et al., 2011) .
Given the nature of band castration-induced wounds (e.g., ischemia, cellular damage, and coagulation necrosis; AVMA, 2012), the current study aimed to test the hypotheses of whether 1) meloxicam's longer half life, relative to flunixin meglumine (Coetzee et al., 2009) , could mitigate painful response to band castration and 2) band castration diminishes performance and induces adverse behavioral and physiological response vs. intact males.
MAtErIALS And MEthodS
All animal handling and procedures were approved by the Colorado State University Institutional Animal Care and Use Committee.
Experiment 1
Animals and Treatments. Angus and Charolais cross bull calves (n = 127; 309.8 ± 59.04 kg initial BW) from a single source were weaned at 240 ± 23.4 d of age. All bulls were weighed, vaccinated, administered tetanus toxoid, dewormed, and assigned radio frequency identification (rFId)-linked ear tags before being shipped 52 km to a feeding facility. Animals were received in large pens for 48 h and offered an ad libitum diet of long-stem grass hay top dressed with 1 kg/animal (DM basis) of the total mixed ration (tMr) that cattle would receive on the trial. On d -5, bulls were processed and assigned to pens (7 animals/pen). Pens were stratified by BW and randomly assigned to 1 of 3 treatments: 1) band castration (BAnd), 2) band castration with oral administration of meloxicam (BAnd-MEL), and 3) sham castration (ShAM). While on trial, the TMR consisted of (DM basis) corn silage (52.9%), cracked corn (21.3%), dried distillers grain (15.0%), wheat straw (8.5%), mineral supplement (2.3%), calcium carbonate, and monensin (Rumensin; Elanco Animal Health, Indianapolis, IN). Every morning orts were collected from each pen and weighed for pen-level DMI and to determine feed allocation for that day. Feed was delivered once daily with adjustments to each pen's delivery amount to achieve near ad libitum feed supply.
The BAND and SHAM procedures were completed on d 0. Band castrations were completed by securing a latex band around of the neck of the scrotum to cause subsequent necrosis of the scrotum and testis using a banding tool (Calicrate Bander; No Bull Enterprises, St. Francis, KS) . Sham bulls were subjected to manipulation of the scrotum associated with castration including palpation of testis and neck of scrotum but without band application. Differences in the time SHAM and BAND bulls spent restrained in the chute were not recorded because, unlike surgical castration, differences in time constraint between sham and band castration were negligible.
Castrates receiving meloxicam were administered 1.0, 0.5, and 0.5 mg/kg on d -1, 0, and 1, respectively, by rounding to the nearest meloxicam tablet (meloxicam 15 mg; Zydus Pharmaceuticals, Pennington, NJ). Tablets were then encapsulated in a porcine gelatin bolus (Torpac Inc., Fairfield, NJ) and administered per os via a stainless steel balling gun. Both SHAM and BAND cattle were given a placebo of an empty gelatin capsule.
Blood Collection. Coccygeal blood samples were collected in 6 mL lithium heparinized vacutainer tubes from the same 3 bulls per pen on d 0, 1, and 8 to provide a general representative sampling of each pen for meloxicam concentration. Plasma was collected by centrifuging for 10 min at 2,000 × g at 4°C. Samples were then stored at -20°C.
Plasma Meloxicam Determination. Plasma concentrations of meloxicam were determined using highpressure liquid chromatography (Surveyor MS Pump and Autosampler; Thermo Scientific, San Jose, CA) with mass spectrometry detection (TSQ Quantum Discovery MAX; Thermo Scientific) at Iowa State University. Plasma samples, plasma spikes, and plasma quality control (Qc) samples (0.200 mL) were treated with 30% perchloric acid (20 μL) after addition of 40 ng/mL of the internal standard piroxicam. The samples were vortexed for 5 s and centrifuged for 20 min at 2,500 × g at 4°C to sediment the precipitate. A portion of supernatant (80 μL) was transferred to an injection vial fitted with a glass insert containing 120 μL of 1.9% ammonium hydroxide in 25% aqueous acetonitrile. The injection volume was set to 12.5 μL. The mobile phases consisted of A, 0.1% formic acid in water, and B, 0.1% formic acid in acetonitrile at a flow rate of 0.225 mL/min. The mobile phase began at 25% B with a linear gradient to 95% B at 7 min, which was maintained for 1.5 min followed by re-equilibration to 25% B. Separation was achieved with a solid-core C18 column (KinetexXB-C18, 100 by 2.1 mm, 2.6 µm particles; Phenomenex, Torrance, CA) maintained at 40°C. Piroxicam eluted at 4.85 min and meloxicam at 5.95 min. Four selected reaction monitoring (SrM) transitions were monitored for meloxicam and 3 SRM transitions were used with the internal standard, piroxicam. The quantifying ions for meloxicam were 72.99, 88.01, 114.99, and 140.98 m/z and 77.97, 94.98, and 120 .98 m/z for piroxicam. Sequences consisting of plasma blanks, calibration spikes, QC samples, and bovine plasma samples were batch processed with a processing method developed in the Xcalibur software (Thermo Scientific). The processing method automatically identified and integrated each peak in each sample and calculated the calibration curve based on a weighted (1/X) linear fit. Plasma concentrations of meloxicam in unknown samples were calculated by the Xcalibur software based on the calibration curve. Results were then viewed in the Quan Browser portion of the Xcalibur software. The standard curve in bovine plasma was linear from 0.005 to 10.0 μg/mL. The correlation coefficient exceeded 0.995 and all measured values were within 15% of the actual values with most of the values less than 5% difference from the actual values. The accuracy of the assay for meloxicam in bovine plasma was 99 ± 3% of the actual concentration whereas the coefficient of variation was 5% determined on 4 sets of replicates for each of the following concentrations: 0.015, 0.15, and 1.5 µg/mL. All samples were analyzed within 90 d of collection.
Behavioral Measurements. Upon restraint of the animal, a single evaluator assigned a subjective chute score (cS) by marking a 15-cm long line scale as described by Gruber et al. (2010) . The evaluator could not be truly blinded to the treatments chute-side as it was apparent that castrations were occurring. Marks were converted to values on a 0 to 5 line scale (0 = calm and 5 = aggressive), which were aimed to be indicative of the animals response to restraint (Gruber et al., 2010) . Rectal temperature (tEMP) was collected after CS was determined on each day. All animals were weighed and assigned a CS in a hydraulic chute (Silencer Inc., St. Francis, KS) on d -5, -1, 0, 1, 8, 14, 21, and 28.
Objective exit velocity (EV) was collected on d -5, -1, 1, 8, 14, 21, and 28 using an infrared laser timing system (Farmtek Inc., Wylie, TX) in Exp. 1. One set of sensors was placed 1.892 m beyond the head catch and the second set was placed 1.892 m beyond the first set. Exit velocity was calculated from the time elapsed between the 2 sets of sensors and reported in meters per second.
Video documentation also occurred at a pen level for 3 d before castration, on d 0 (immediately postcastration), and for 3 d postcastration, for 2 h in the morning and 2 h in the evening. Video footage of individual 15 s clips for each pen was taken every 15 min. These clips were retrospectively analyzed by a third party blinded to all treatments and study design. Data were reported as proportion of the pen (animals clearly distinguishable in the frame) standing, walking, lying lateral, lying sternal, at the feedbunk, and at the water tank.
Statistical Analyses. Experimental unit was pen. Weekly averages for DMI were analyzed in a mixed repeated measures model (PROC GLIMMIX, SAS Inst. Inc., Cary, NC). Precastration DMI did not differ (P > 0.10) across treatments; therefore, a precastration DMI value was not included as a covariate. Rectal temperature and ADG were studied in a repeated measures mixed model using mean values from d -1 and 0 as covariates. In a similar fashion, CS and EV were studied although mean d -5 and -1 values were used as covariates. Within repeated measures models, time was considered a factor and examined for interactions. The random effect was pen within treatment.
Gain to feed ratio was analyzed using mean ADG divided by mean trial DMI·hd -1 ·d -1 with d -1 and 0 BW used as a covariate in a mixed model (PROC GLIMMIX of SAS).
The proportion of animals within a pen was determined by comparing the number of animals participating in a given activity divided by the total number of animals that could be distinguished in each frame of the footage. These proportions were studied in a generalized linear mixed repeated measures model, which applied a logit transformation. Numeric mean proportions were reported although transformed values were used in simple comparisons (PROC GLIMMIX of SAS). Orthogonal contrasts were completed by contrasting BAND and BAND-MEL, and then pooled castrate values (BAND and BAND-MEL) were compared to SHAM for all response variables (LSMESTIMATE of SAS).
Experiment 2
To more closely explore specific behavioral and physiological aspects at the time of band castration, purebred Hereford and Angus and Hereford × Angus crossbred bulls (n = 30, 300.8 ± 4.96 kg) were stratified by BW and randomly assigned to 1 of 3 treatments: 1) BAND, 2) BAND-MEL, and 3) SHAM. Bulls were housed in 3 adjacent pens with 10 animals/pen and fed an ad libitum diet consisting of (DM basis) corn silage (52.9%), cracked corn (21.3%), dried distillers grain (15.0%), wheat straw (8.5%), and mineral supplement (2.3%) via a TMR.
The BAND and SHAM procedures were completed on d 0 as described in Exp. 1. Castrates receiving meloxicam were administered 1.0, 0.5, and 0.5 mg/kg on d -1, 0, and 1, respectively, as described in Exp. 1.
Blood Collection. Jugular blood samples were collected using 18 gauge 3.81 cm sterile needles and a syringe on d 0, 1, and 7 for SP concentration. Blood was then transferred immediately into a sterile 6 mL lithium hepa-rinized vacutainer tube and immediately placed on ice for transport for processing. Plasma meloxicam was analyzed using the same method as in Exp. 1.
Blood samples for SP were injected in 10 mL EDTA vacutainer tubes, which were prepared with a benzamidine so that, with blood, the concentration was 1 mM benzamidine. After benzamidine was added, tubes remained on ice until blood injection. Blood samples were immediately centrifuged at 1,700 × g at 4°C chute-side and plasma was immediately placed on ice until transport within 3 h to a -80°C freezer until analysis. Analysis was conducted as previously described by Coetzee et al. (2008) .
Behavioral Measurements. Upon restraint in a hydraulic chute (Silencer Inc.), a subjective CS was assigned as described in Exp. 1. Rectal temperature was collected after CS was determined on each day and bulls were weighed. These data were collected on d -1, 0, 1, 7, 14, and 21.
Video documentation at the time of castration or sham treatment was collected on a subset of bulls (n = 19). Video data were studied using video analysis software (Dartfish Inc., Alpharetta, GA). This was a modified version of collection as noted by Schwartzkopf-Genswein et al. (1998) , in which they examined the effect of hot-iron branding, freeze branding, and sham branding on head movement and velocity. The current experiment examined the maximum vertical range of head movement (dISt) during the procedure as noted by differences in highest and lowest points of the nose in the frame of the video (Fig. 1) .
Statistical Analyses. Individual animal was the experimental unit. A repeated measures analysis of covariance was used with d -1 and d 0 values used as covariates to study TEMP, SP, and BW (PROC MIXED of SAS). Mean ADG was calculated using average BW for d -1 and 0 as the initial value. Plasma meloxicam values were presented as least square means by treatment group. Rectal temperature and CS were examined over time by studying least squares mean value differences across treatments on a given day by including numeric day in the model statement. When there were no differences (P > 0.10) across treatments of castrations, orthogonal contrasts were completed for all response variables, contrasting BAND and BAND-MEL and pooled castrate values (BAND and BAND-MEL) and SHAM values. Analysis of DIST data was conducted using a Tukey's adjustment for unbalanced sampling (PROC MIXED of SAS), as a greater proportion of animals documented were castrated. If values associated with BAND and BAND-MEL were similar (P > 0.10), values were averaged and compared to SHAM using orthogonal contrast (LSMESTIMATE by SAS).
rESuLtS

Experiment 1
Average daily gain did not differ between BAND and BAND-MEL (P = 0.62). However, when SHAM was compared to pooled BAND and BAND-MEL treatments, SHAM bulls exhibited greater ADG (P = 0.0003; Table 1 ) than banded bulls.
There were no differences (P ≥ 0.66) for DMI between BAND and BAND-MEL or between castrates and sham cattle. When week was included in the model, mean DMI was greater (P = 0.01) during wk 4 for SHAM cattle than BAND and BAND-MEL treatments. At no point did DMI differ (P ≥ 0.66) between BAND and BAND-MEL (Table 1) .
There were no differences (P = 0.40) between BAND and BAND-MEL for G:F. However, SHAM cattle exhibited greater G:F than castrates throughout the trial (Table 1) .
Overall CS did not differ (Table 1) between BAND and BAND-MEL (P = 0.62) nor did it differ when castrates were pooled and compared to SHAM (P = 0.14). When day was included in the model, castrates exhibited less desirable CS than SHAM on d 1 (P = 0.01) and 28 (P = 0.03).
Overall EV tended (P = 0.06; Table 1 ) to be greater for castrates than SHAM. There was a tendency (P = 0.06) for castrates to exhibit greater EV than SHAM on d 8 and 14. On d 28, castrates exhibited greater (P = 0.02) EV than SHAM. Meloxicam did not impact EV at any point (P ≥ 0.40) during the trial.
Overall mean TEMP did not differ (P = 0.61) between BAND and BAND-MEL, nor did castrates differ (P = 0.53) from SHAM. When day was included in the model, there was no effect (P ≥ 0.18) of either meloxicam or castration on any given day measured (Table 1) .
Pen-level video footage on d 0 revealed a greater proportion (P = 0.03; Table 2 ) of animals at the bunk in a pen for SHAM treatments vs. castrates at 15 min postcastration. Percentage of SHAM cattle at the bunk tended (P = 0.08) to be greater than castrates at 45 min but did not differ (P ≥ 0.10) between castrates and SHAM at any other time. Meloxicam treatment had no effect (P ≥ 0.30; Table 2 ) at any time point within 120 min postcastration 2 CAST = contrast between pooled BAND and BAND-MEL means and SHAM means.
3 MELOX = contrast between BAND and BAND-MEL means.
4 Upon restraint, cattle were assigned a subjective CS with 1 = calm and 5 = aggressive as noted by Gruber et al. (2010) .
5 Chute EV was collected as the velocity from 1.892 to 3.784 m beyond the head catch using an electronic infrared barrier system. 6 TEMP was collected on d -1, 0, 1, 8, 14, 21, and 28. Least squares means for d 1, 8, 14, 21, and 28 were calculated using d -1 and 0 as a covariate.
7 Plasma meloxicam was collected on d 0, 1, and 8 from a subset of BAND-MEL animals only.
8 NC = plasma samples were not collected from either BAND or SHAM animals to determine meloxicam concentration. on pen bunk behavior. Average percentage of cattle at the bunk on d 1 was greater (P < 0.001; Table 3 ) for BAND than BAND-MEL, but percentage of cattle at the bunk did not differ (P = 0.35) between pooled castrate values and SHAM. That said, on d 1 a greater (P = 0.01) percentage of SHAM cattle were at the bunk than BAND-MEL whereas a greater (P = 0.001) percentage of BAND cattle were at the bunk than SHAM cattle.
Percentage of animals at the water tank immediately postcastration did not differ between BAND and BAND-MEL or between castrates and SHAM cattle at any time points on d 0 or on d 1, 2, or 3 (P ≥ 0.13; Tables 2 and 3) .
When percentage of pen standing in the frame of the video was examined, a greater (P = 0.02) proportion of BAND cattle were standing than BAND-MEL cattle immediately postcastration (Table 2 ). There were no other differences between BAND and BAND-MEL on d 0. Castrates and SHAM were similar (P ≥ 0.28) in percentage of cattle standing in the pen at every time point throughout the 120-min observation period on d 0. On d 1, BAND-MEL exhibited a greater (P = 0.001) percentage of cattle standing than BAND. There was no difference (P = 0.44) between pooled castrate values vs. percentage of SHAM standing. Similarly on d 2 and 3, a greater (P = 0.01; Table 3 ) percentage of BAND-MEL cattle were standing than BAND cattle. On d 3, SHAM castrates exhibited a greater (P < 0.001) percentage of cattle standing than pooled castrates.
There were no differences (P ≥ 0.14; Tables 2 and 3) in percentage of cattle in a pen walking between BAND and Cattle lying in the pen were divided into sternal and lateral classification. There was a tendency for a greater (P = 0.06; Table 2 ) percentage of BAND-MEL at 120 min postcastration to be lateral recumbent. There were no differences (P ≥ 0.47) between SHAM and castrates for lateral recumbence during the 120-min period postcastration. On d 1, castrates exhibited a greater (P = 0.04; Table 3 ) percentage of cattle that were lateral recumbent. Percentage of cattle lateral recumbent did not differ (P ≥ 0.12) on d 2 or 3.
Percentage of cattle in the sternal position was greater (P = 0.03; Table 2) in castrates than SHAM at 60 min postcastration. There was also a tendency (P = 0.08 and P = 0.06, respectively) for castrates to exhibit sternal lying at a greater rate at 30 min and 120 min postcastration than SHAM. Sternal response was similar (P ≥ 0.14) for BAND and BAND-MEL throughout the 120-min period postcastration on d 0. On d 1, a greater (P = 0.03; Table   3 ) percent of SHAM cattle were sternal recumbent than castrates. There was a tendency (P = 0.08) for SHAM cattle to have a greater percentage of cattle sternal recumbent than castrates on d 2.
Experiment 2
Average daily gain did not differ across treatments (P = 0.17; data not reported). However, when contrasted with pooled values of castrates, SHAM bulls had a tendency (P = 0.07) to exhibit greater ADG. Both groups of castrates experienced negative ADG over the 21-d trial whereas SHAM bulls experienced positive gain.
Video analysis revealed that when compared to SHAM cattle, castrates exhibited greater DIST (P = 0.04) whereas DIST did not differ (P = 0.57) between BAND and BAND-MEL (Table 4) .
Overall CS did not differ (P = 0.84; Table 5 ) across BAND and BAND-MEL or between castrates and SHAM. Furthermore, when treatment × day interactions were examined, neither BAND and BAND-MEL nor castrates and SHAM on a given day differed (P ≥ 0.41) although there was a day effect (P < 0.05) independent of treatment (Table 5) in which mean CS declined throughout the study.
Overall mean TEMP did not differ (P = 0.66) between castrates and SHAM, but BAND-MEL cattle had greater (P < 0.05) TEMP than BAND (Table 5) . When evaluated over time, there was a treatment × day interaction (P = 0.001; Table 5 ). On d 7, BAND-MEL tended (P = 0.09) to have greater TEMP than BAND. On d 14, banded cattle exhibited greater (P = 0.004) TEMP than SHAM whereas BAND and BAND-MEL did not differ (P = 0.77). On d 21, TEMP was greater (P = 0.03) for BAND-MEL than BAND and SHAM had greater (P = 0.001) TEMP than BAND. On any other day, TEMP did not differ across treatments (P ≥ 0.29). Plasma SP values did not differ across treatments (P = 0.81; Table 5 ). No meloxicam was detected in blood samples from either BAND or SHAM on d 0 or d 7; plasma meloxicam was greater in BAND-MEL than BAND (P < 0.001) and SHAM (P < 0.001) on d 0. Plasma meloxicam samples for d 1 were not collected for BAND or SHAM treatments; therefore, comparisons could not be made on d 1.
dIScuSSIon
Results from both Exp. 1 and 2 indicate no impact of oral meloxicam on ADG. Experiment 1 revealed that castration does have an adverse impact on ADG in beef bulls, with SHAM bulls exhibiting greater ADG than castrates. These results concur with findings of a previous study examining oral meloxicam at surgical castration (Coetzee et al., 2011) where meloxicam had no impact on ADG. Although our results were unique with castrates exhibiting a loss of BW in Exp. 2, in previous studies castrates exhibited reduced ADG when compared to intact bulls (Fisher et al., 2001 ). Although differences were not observed for ADG in Exp. 2, the results of Exp. 1 suggest that the lack of a difference in Exp. 2 was a function of sample size being insufficient for a 21-d feeding period used in Exp. 2.
Similarities in DMI in Exp. 1 suggest that neither castration nor oral administration of meloxicam impacted overall DMI. That said, castrates exhibited reduced DMI in the fourth week of the trial, but at no point did BAND and BAND-MEL differ, suggesting no impact of oral meloxicam in association with castration on DMI. Experiment 1 of the current study used pen-level DMI for 28 d postcastration. Future studies using RFID-linked feedbunks would allow for individual bull to be the experimental unit while also providing feeding behaviors beyond DMI. These feeding behaviors could help determine the impact of pain mitigation in association with castration on parameters beyond commonly accepted performance traits.
Subjective CS, as used in the current study, has only been studied in the performance of beef cattle as a measure of disposition. Gruber et al. (2010) noted differences in carcass and feedlot performance associated with CS, but there is no evidence in the literature that this measurement has been used in association with castration. These similarities could likely be a function of band castration's minimal impact, or it may also be attributed to the fact that these animals had been well acclimated to handling by the time of castration and subsequently did not exhibit differences in CS response. In Exp. 1, on d 28 both mean EV and CS were greater (P < 0.05) than for previous day. It is unclear why this occurred although due to the relationship that has been shown between EV and CS (Repenning et al., 2011) , clearly animals displayed less desirable dispositions on the last day of the trial.
In relation to TEMP in Exp 2, differences on d 14 may indicate that by d 14 band castration increased inflammatory mediators to cause a rise in TEMP. Day 21 results are likely unrelated to the castration procedure.
In Exp. 2, SP, a neuropeptide that has shown promise in objectively identifying painful response (Coetzee et al., 2008) was not different between band castration and SHAM nor was there an impact of oral meloxicam. The similar SP values may be due to the collection in- 2 CAST = contrast between pooled BAND and BAND-MEL means and SHAM means.
4 Subjective CS was determined on head restraint as previously noted by Gruber et al. (2010) .
5 TEMP was collected on d -1, 0, 1, 7, 14, and 21. Least squares means for d 1, 7, 14, and 21 were calculated using d -1 and 0 as a covariate.
6 Plasma SP was collected on d 0 immediately before castration or sham castration and on d 1 on restraint in the head catch. Samples were analyzed as described by Coetzee et al. (2008) . Means for d 1 were analyzed using d 0 means as a covariate.
7 Plasma meloxicam samples were collected on d 0, 1, and 7, and analyzed using HPLC.
8 Samples for plasma meloxicam concentration on d 1 for BAND and SHAM were not collected (NC).
terval used in the current study, as previous studies examined SP associated with surgical castration collected 10 times over 4 h postcastration (Coetzee et al., 2008) . The current study used a greater collection interval (immediately before castration and 24 h after) with the hypothesis that band castration would induce a delayed SP response relative to surgical castration as used in the previous study (Coetzee et al., 2008) . Although the hypothesis, to the best of our knowledge, has not been tested, another explanation for the similarity may be that band castration does not elicit as marked a response in SP concentration as surgical castration in bulls; for example, at 24 h postcastration there is not yet sufficient pain to elicit a marked SP response. Additionally, given the instability of this neuropeptide, there is potential that SP degraded during processing of the samples although all samples would have undergone the same degradation.
Future studies associated with SP and band castration are needed to determine the most advantageous time interval to isolate peaks in SP response. Onuoha and Alpar (1999) studied healthy human controls and humans experiencing some variety of acute soft tissue damage and found that injured patients exhibited 27-fold greater SP than healthy controls. The current study did not reveal similar results in regard to band castrates vs. SHAM. However, this may be because band castration does not elicit tissue damage analogous to the human subjects in the previous study, thus not inducing significantly higher SP concentrations. An additional explanation may be that tissue damage associated with band castration occurred later in the study as the scrotal and testicular tissue began to slough.
Bioavailability of oral meloxicam, as evident with plasma concentrations, appeared to adequately achieve therapeutic levels in cull beef bulls. This was verified by comparing plasma meloxicam levels to median plasma meloxicam levels in a previous study that administered 1.0 mg/kg oral meloxicam (Coetzee et al., 2009) . The authors used a small sample size (n = 6) of Holstein calves but found similar median plasma meloxicam concentration as the current study. Although in the current study meloxicam had a negligible impact on bulls at castration, there may be further application outside the realm of band castration.
Head movement associated with castration in the current study revealed that castration, regardless of meloxicam administration, induced a greater resistance behavior than SHAM. A previous study noted differences in DIST across method of branding (hot iron, freeze, and sham) with hot-iron branding eliciting the greatest DIST response (Schwartzkopf-Genswein et al., 1998) . Although the current study examined castration, we can assume that DIST is indicative of the magnitude of pain response. Results of the current study suggest that meloxicam does not impact DIST. It is likely that meloxicam's anti-inflammatory effect may have been limited to mitigation of acute pain associated with application of a band. Further investigation into painful behaviors and means of alleviating said behaviors will be critical in approving new drugs for pain mitigation.
Video documentation for 120 min postcastration revealed an impact of castration on percentage of animals at the bunk 15 min postcastration and on percentage of bulls sternal recumbent 60 min postcastration. Oral meloxicam administration had no impact on pen-level behaviors documented at any point during the 120-min postcastration observation period. Results from the current study differ from those of a previous study that examined the effects of oral meloxicam (0.5 mg/kg) at dehorning in Holstein calves in which meloxicam-treated calves spent a greater percentage in recumbence than placebo control calves on d 1, 2, 3, and 4 postdehorning (Theurer et al., 2012) . This inconsistency could be attributed to the acute pain associated with scoop dehorning vs. band castration, which involves progressive necrosis of the testis. Perhaps a greater number of animals within each pen or evaluating on an individual-animal level in future studies would allow for differences to be observed. A previous study using Angus bulls (n = 46) and steers (n = 43) as controls examined the effect of xylazine epidural and flunixin meglumine in association with band castration and found no difference due to the main effects of castration or medication on percent of cattle lying (González et al., 2010) . Similarly, the current study found no effect of medication on percentage of cattle lying in the pen although certain time points revealed differences in the percentage of castrated cattle lateral recumbent vs. SHAM. González et al. (2010) found rear leg step length postcastration was greater in both previously castrated steers and across the main effect of medication, but this analysis was conducted on a total of 8 animals/treatment. The current study was not able to document step length with sufficient accuracy; therefore, step length was not measured.
Pen-level video data revealed BAND-MEL cattle exhibited a smaller percentage of cattle at the feedbunk on d 1, 2, and 3 than both BAND and SHAM. These data were not reaffirmed by DMI differences in week 1, assuming that there was a compensatory effect that equilibrated by d 7.
Percentage of cattle at the water tank or walking did not differ across meloxicam treatment or castration. These similarities suggest that these behaviors may not be valuable in defining different behavioral patterns in association with band castration and oral meloxicam administration at the time-frame observed in the current study.
The greater percentage of lateral recumbence in castrates on d 1 vs. SHAM indicates that at 24 h postcastration there was a behavioral impact of castration. Lateral recumbence may be a response to discomfort or pain, but the current study has no means of making this conclusion.
Previous studies investigating mulesing of Merino lambs performed pen-level observations after mulesing or sham in association with meloxicam or tolfenamic acid (Paull et al., 2008) . Like castration, mulesing is a husbandry practice scrutinized for its impact on animal pain. The authors found that mulesed lambs, regardless of NSAID treatment, displayed similar behaviors in the pen (i.e., lying sternal, lying lateral, standing, or walking). Mulesed lambs, regardless of NSAID treatment, also spent a greater portion of time standing hunched, as compared to sham lambs that spent a greater portion of time lying. The previous study administered NSAIDs at the time of mulesing or 45 min before mulesing. This time interval may not have been adequate to prevent initial inflammatory response to mulesing-induced tissue damage. As well, both tolfenamic acid and meloxicam are cyclooxygenase (coX) 2 specific NSAIDs (and thus embody a favorable COX 2:1 ratio), which are advantageous in avoiding adverse gastrointestinal problems (Griswold and Adams, 1996) . However, one would assume there would be adequate analgesia later in the observation period although hyperalgesia may have already taken place by the time of peak drug levels.
Both Exp. 1 and 2 in the current study used a sample size of weaned cattle with greater BW than most previously published research. Although feeder calves being castrated postweaning is typically a function of managerial restraints, there is a large population of seedstock producers that cannot castrate before a bull's phenotype (e.g., weaning weight, postweaning gain, yearling weight, and conformation) can be fully evaluated. Further studies examining the effect of age at castration is important for bettering our understanding of pain response to castration, but there is still a need to examine the effects of postweaning castration to address this sector of the beef industry.
Similar to results of a previous study investigating oral meloxicam in association with surgical castration (Coetzee et al., 2011) , the current study revealed no impact of oral meloxicam on ADG. The authors of the previous study found that meloxicam impacted some aspects of morbidity but no behavioral or feedlot performance parameters when compared to other castrates.
Continuing to investigate the impact of pain mitigation in association with castration on behavior is imperative in addressing societal concerns over castration. Furthermore, the literature must expand in the field of pain mitigation to approve effective products for pain management at castration.
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